Bellevue Life Sciences Acquisition (BLAC) Competitors $0.56 0.00 (-0.16%) As of 08/13/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BLAC vs. ICU, LUCY, CODX, POAI, SSKN, PAVM, HSCS, LFWD, SINT, and STRRShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include SeaStar Medical (ICU), Innovative Eyewear (LUCY), Co-Diagnostics (CODX), Predictive Oncology (POAI), Strata Skin Sciences (SSKN), PAVmed (PAVM), HeartSciences (HSCS), Lifeward (LFWD), Sintx Technologies (SINT), and Star Equity (STRR). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Its Competitors SeaStar Medical Innovative Eyewear Co-Diagnostics Predictive Oncology Strata Skin Sciences PAVmed HeartSciences Lifeward Sintx Technologies Star Equity Bellevue Life Sciences Acquisition (NASDAQ:BLAC) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Which has better valuation & earnings, BLAC or ICU? Bellevue Life Sciences Acquisition has higher earnings, but lower revenue than SeaStar Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/ASeaStar Medical$140K70.40-$24.83M-$2.62-0.34 Which has more risk & volatility, BLAC or ICU? Bellevue Life Sciences Acquisition has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.04, suggesting that its stock price is 204% less volatile than the S&P 500. Is BLAC or ICU more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to SeaStar Medical's net margin of -1,915.27%. Company Net Margins Return on Equity Return on Assets Bellevue Life Sciences AcquisitionN/A N/A N/A SeaStar Medical -1,915.27%N/A -261.34% Does the media prefer BLAC or ICU? In the previous week, SeaStar Medical had 6 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 6 mentions for SeaStar Medical and 0 mentions for Bellevue Life Sciences Acquisition. SeaStar Medical's average media sentiment score of 0.59 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media. Company Overall Sentiment Bellevue Life Sciences Acquisition Neutral SeaStar Medical Positive Do insiders & institutionals hold more shares of BLAC or ICU? 55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 33.7% of Bellevue Life Sciences Acquisition shares are owned by company insiders. Comparatively, 1.3% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryBellevue Life Sciences Acquisition beats SeaStar Medical on 5 of the 8 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$12.16M$220.39M$2.54B$9.84BDividend YieldN/A3.23%2.55%4.07%P/E RatioN/A1.9722.2225.74Price / SalesN/A553.7084.42115.79Price / CashN/A115.7723.7359.48Price / BookN/A8.8733.046.15Net IncomeN/A-$10.81M$31.01M$265.06M7 Day Performance-9.35%-0.35%0.66%2.60%1 Month Performance-52.45%0.01%1.96%2.83%1 Year Performance-94.81%156.03%29.95%25.58% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$0.56-0.2%N/A-94.9%$12.16MN/A0.00N/AHigh Trading VolumeICUSeaStar Medical0.3322 of 5 stars$0.80+7.0%N/A-82.4%$8.97M$140K-0.232Earnings ReportShort Interest ↑LUCYInnovative Eyewear0.8596 of 5 stars$1.96-0.5%N/A-44.6%$8.96M$1.64M-0.499News CoverageEarnings ReportShort Interest ↓CODXCo-Diagnostics4.5803 of 5 stars$0.25+0.2%$5.50+2,086.9%-78.1%$8.44M$3.91M-0.21100News CoverageEarnings ReportShort Interest ↓Gap UpPOAIPredictive Oncology1.604 of 5 stars$0.82+5.9%$3.00+268.1%-1.1%$8.33M$1.73M-0.2730News CoverageEarnings ReportGap UpSSKNStrata Skin Sciences2.3725 of 5 stars$1.91-2.1%$6.00+214.1%-33.0%$7.97M$33.56M-0.84120News CoverageEarnings ReportShort Interest ↑PAVMPAVmed4.6093 of 5 stars$0.46-5.3%$19.00+3,993.1%-36.6%$7.93M$2.99M0.6590News CoverageHSCSHeartSciences3.3842 of 5 stars$3.50-3.0%$13.00+271.4%+5.1%$7.84MN/A-0.3710Short Interest ↓High Trading VolumeLFWDLifeward2.7206 of 5 stars$0.70-0.9%$9.00+1,187.6%-80.3%$7.70M$25.66M-0.2360Trending NewsSINTSintx Technologies3.0879 of 5 stars$2.69+1.5%$28.00+940.9%-27.6%$7.42M$2.89M-0.0540Earnings ReportShort Interest ↓STRRStar Equity2.5797 of 5 stars$2.02+2.0%$5.00+147.5%-45.0%$6.53M$53.36M-0.59460News CoverageEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies ICU Competitors LUCY Competitors CODX Competitors POAI Competitors SSKN Competitors PAVM Competitors HSCS Competitors LFWD Competitors SINT Competitors STRR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLAC) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access